Abstract
Today foods are not intended only to satisfy hunger and to provide necessary nutrients for humans but also to prevent nutrition-related diseases and improve physical and mental well-being of the consumers. The increased knowledge on the relationship between nutrients and health has resulted in several new product categories, such as functional foods and nutraceuticals. A function food is one which demonstrates to affect beneficially one or more target functions in the body, beyond its nutritional effects. Functional foods are concerned with the prevention of disease or reduction of disease risk, but cannot make any claims as to cures. The term nutraceuticals was first introduced by DeFelice in 1989 and in 1994 defined as “any substance that may be considered a food or part of a food which provides medical or health benefits, including the prevention and treatment of disease” (DeFelice in What is a true nutraceutical?—and—What is the nature & size of U.S. nutraceutical market? The Foundation for Innovation in Medicine, Cranford, 1994). Nutraceuticals are functional foods capable of modifying one or more organic functions favorably in addition to their nutritional effect. Probiotics and omega-3 fatty acids are the important nutraceutical ingredients that promise maximum growth over the next five years. Out of various groups of nutraceuticals, the most sought group is the products containing or enriched with omega-3 fatty acids. This article reviews the world market of such products.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ALA:
-
Alpha-linolenic acid
- EPA:
-
Ecosapentanoic acid
- DHA:
-
Docosahexanoic acid
- SDA:
-
Stearidonic acid
- AA:
-
Arachidonic acid
- GOED:
-
Global Organization for EPA & DHA
- PUFA:
-
Polyunsaturated fatty acid
- CAGR:
-
Compound annual growth rate
- USFDA:
-
United States of America Food and Drug Administration
- RDI:
-
Recommended daily intake
- FAO:
-
Food and Agriculture
- WHO:
-
World Health Organization
- IBD:
-
Irritable bowel syndrome
- OTC:
-
Over the counter
- US:
-
USA
- EU:
-
European Union
- TCI:
-
Technology Crops International
- GLA:
-
Gamma-linolenic acid
- EC:
-
European Commission
References
DeFelice ST. What is a true nutraceutical?—and—What is the nature & size of the U.S. nutraceutical market? Cranford: The Foundation for Innovation in Medicine; 1994.
Mollet B, Rowland I. Functional foods: at the frontier between food and pharma. Curr Opin Biotechnol. 2002;13(5):483–5.
Young Y. Functional foods and the European consumer. In: Buttriss J, Saltmarsh M, editors. Functional foods. II. Claims and evidence. London: The Royal Society of Chemistry; 2000.
Palthur MP, Palthur SS, Chita SK. Nutraceuticals: a conceptual definition. Int J Pharm Pharm Sci. 2010;2(3):19–27.
Eur-lex.europa.eu [Internet]; 2012. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32002L0046:EN:NOT.
Eur-lex.europa.eu [Internet]; 2012. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2006R1924:20080304:EN:PDF.
Novel foods and novel food ingredients [Internet]; 2012 [Updated 18 Dec 2013]. Available From: http://ec.europa.eu/food/food/biotechnology/novelfood/initiatives_en.htm.
Tewfik S, Tewfik I. Nutraceuticals, functional foods and botanical dietary supplements; promote wellbeing and underpin public health. World Rev Sci Technol Sustain Dev. 2008;5(2):104–23.
Hsieh YH, Ofori JA. Innovations in food technology for health. Asia Pac J Clin Nutr. 2007;16(1):65–73.
Menrad K. Market and marketing of functional food in Europe. J Food Eng. 2003;56:181–8.
Ahmad F, Ashraf SA, Ahmad FA, Ansari JA, Siddiquee RA. Nutraceutical market and its regulation. Am J Food Technol. 2011;6(5):342–7.
India to increase biotech research ties with EU [Internet]; 2008 [Updated 25 Dec 2008]. Available from: http://ec.europa.eu/research/biosociety/news_events/news_india-eu_en.htm.
Verbeke W. Consumer acceptance of functional foods: socio-emographic, cognitive and attitudinal determinants. Food Qual Prefer. 2005;16:45–57.
Hilliam M. Functional food: how big is the market? World Food Ingredients. 2000;12:50–3.
Burdge GC, Calder PC. Conversionof α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005;45:581–97.
Burdge GC, Wootton SA. Conversion of a-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002;88:411–20.
Grebow J. Everywhere omega fatty acids. Nutr Outlook—Friday, 22 June 2012.
GOED: Global Organization for EPA and DHA Omega-3 [Internet]; 2012. Available from: Website http://www.goedomega3.com http://nccam.nih.gov/health/omega3.
Schofield Lisa. The OMEGA 3 market: essentially innovative. Nutr World. 2013;16(7):3.
Omega-3 PUFA Market by Type (DHA, EPA, ALA), Marine (Fish, Algal, Krill, Others), Plant (Flaxseed, Chia Seed, Others), Application (Dietary supplement, Functional F&B, Pharma, Infant Formula, Others) and Geography—Global Trend and Forecast to 2019. By: marketsandmarkets.com Publishing Date: September 2014, Report Code: FB 2759.
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market overview [Internet]. Available from: http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acids-PUFAs---A-Global-Market-Overview.
Berry B. Health and wellness trends for canada and the world. October 2011.
Christopher S. The changing dynamics of omega 3 industry. Natural product, insider content library. 5 Sep 2012.
Nutraceuticals and Functional Foods. Research Reports in nutraceuticals and functional foods. Omega 3 market analysis and segment forecasts to 2020, Published: February 2014. ISBN Code: 978-1-68038-079-8.
Albert T. Omega-3s: health benefits and delivery forms. Somerset: Catalent Pharma Solutions.
Boran G, Joe MR. Fish gelatin. Adv Food Nutr Res. 2010;60:119–43.
Richardson AJ, Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005;115(5):1360–6.
Catalent Pharma Solutions stability data.
Starling S. GOED: pharma is important for omega 3 but growing slowly. 25 Feb 2013.
Grebow J. FDA Approves three more omega-3 drugs. Is this good or bad news for supplements. Nutr Outlook—4 June 2014.
Jennie Y. Effect of breast milk versus infant formulae on cognitive development. J Dev Disabil. 2007;13(1):2007.
Packaged facts. Global market for EPA/DHA Omega 3 Products; Sept 2012.
Canadian Flax Industry Update. Agriculture and agri food Canada. Spring 2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Panse, M.L., Phalke, S.D. (2016). World Market of Omega-3 Fatty Acids. In: Hegde, M., Zanwar, A., Adekar, S. (eds) Omega-3 Fatty Acids. Springer, Cham. https://doi.org/10.1007/978-3-319-40458-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-40458-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40456-1
Online ISBN: 978-3-319-40458-5
eBook Packages: MedicineMedicine (R0)